96 related articles for article (PubMed ID: 7805753)
21. Human B-cell growth-inhibitory activity of eosinophil cationic protein.
Kimata H; Yoshida A; Ishioka C; Jiang Y; Mikawa H
Biotechnol Ther; 1992; 3(3-4):137-49. PubMed ID: 1303727
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 8 (IL-8) inhibits the interleukin 4 (IL-4)-induced but not the spontaneous growth of human B cells via mechanisms that may involve protein kinase C.
Kimata H; Fujimoto M; Lindley I; Furusho K
Biochem Biophys Res Commun; 1995 Feb; 207(3):1044-50. PubMed ID: 7864891
[TBL] [Abstract][Full Text] [Related]
24. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
Albanesi C; Cavani A; Girolomoni G
J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.
Lorré K; Fransen L; Ceuppens JL
Eur Cytokine Netw; 1992; 3(3):321-30. PubMed ID: 1353987
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines.
Totpal K; Aggarwal BB
Cancer Res; 1991 Aug; 51(16):4266-70. PubMed ID: 1651157
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody against the human peripheral lymph node homing receptor homologue (Leu 8) inhibits B cell differentiation but not B cell proliferation.
Murakawa Y; Strober W; James SP
J Immunol; 1991 Jan; 146(1):40-6. PubMed ID: 1701799
[TBL] [Abstract][Full Text] [Related]
28. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells.
Perussia B; Chan SH; D'Andrea A; Tsuji K; Santoli D; Pospisil M; Young D; Wolf SF; Trinchieri G
J Immunol; 1992 Dec; 149(11):3495-502. PubMed ID: 1358972
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-12 activates human gamma delta T cells: synergistic effect of tumor necrosis factor-alpha.
Ueta C; Kawasumi H; Fujiwara H; Miyagawa T; Kida H; Ohmoto Y; Kishimoto S; Tsuyuguchi I
Eur J Immunol; 1996 Dec; 26(12):3066-73. PubMed ID: 8977306
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-gamma and IL-4.
Takashima T; Ohnishi K; Tsuyuguchi I; Kishimoto S
J Immunol; 1993 Apr; 150(7):3002-10. PubMed ID: 8454870
[TBL] [Abstract][Full Text] [Related]
31. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
32. IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta.
Sandborg CI; Imfeld KL; Zaldivar F; Wang Z; Buckingham BA; Berman MA
J Immunol; 1995 Dec; 155(11):5206-12. PubMed ID: 7594531
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory influence of IL-4 on human B cell responsiveness.
Jelinek DF; Lipsky PE
J Immunol; 1988 Jul; 141(1):164-73. PubMed ID: 2837507
[TBL] [Abstract][Full Text] [Related]
34. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.
Scheurich P; Thoma B; Ucer U; Pfizenmaier K
J Immunol; 1987 Mar; 138(6):1786-90. PubMed ID: 3029221
[TBL] [Abstract][Full Text] [Related]
35. Human recombinant IL-3 is a growth factor for normal B cells.
Xia X; Li L; Choi YS
J Immunol; 1992 Jan; 148(2):491-7. PubMed ID: 1729368
[TBL] [Abstract][Full Text] [Related]
36. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
Owen-Schaub LB; Gutterman JU; Grimm EA
Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of gangliosides on human IgE and IgG4 production.
Kimata H
Eur J Immunol; 1995 Jan; 25(1):302-5. PubMed ID: 7843249
[TBL] [Abstract][Full Text] [Related]
38. Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes.
Erikstein BK; Smeland EB; Blomhoff HK; Funderud S; Prydz K; Lesslauer W; Espevik T
Eur J Immunol; 1991 Apr; 21(4):1033-7. PubMed ID: 1850359
[TBL] [Abstract][Full Text] [Related]
39. Nerve growth factor specifically induces human IgG4 production.
Kimata H; Yoshida A; Ishioka C; Kusunoki T; Hosoi S; Mikawa H
Eur J Immunol; 1991 Jan; 21(1):137-41. PubMed ID: 1991484
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor-alpha and interleukin 6 synergistically induce T cell growth.
Kuhweide R; Van Damme J; Ceuppens JL
Eur J Immunol; 1990 May; 20(5):1019-25. PubMed ID: 2358016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
